ILLUMET Trademark

Trademark Overview

On Thursday, April 4, 2019, a trademark application was filed for ILLUMET with the United States Patent and Trademark Office. The USPTO has given the ILLUMET trademark a serial number of 79260099. The federal status of this trademark filing is REGISTERED as of Tuesday, March 16, 2021. This trademark is owned by Telix Pharmaceuticals Limited. The ILLUMET trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Chemicals for radiopharmaceuticals for diagnostic uses; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses

Infusion and injection devices for preparing and administering diagnostic radiopharmaceuticals; apparatus to prepare diagnostic radiopharmaceuticals for delivery; diagnostic imaging apparatus for imaging radiopharmaceuticals, namely, vials, solutions, and infusion devices for preparing and administering diagnostic radiopharmaceuticals
illumet

General Information

Serial Number79260099
Word MarkILLUMET
Filing DateThursday, April 4, 2019
Status700 - REGISTERED
Status DateTuesday, March 16, 2021
Registration Number6291477
Registration DateTuesday, March 16, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements

Goods and ServicesChemicals for radiopharmaceuticals for diagnostic uses; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses
Goods and ServicesInfusion and injection devices for preparing and administering diagnostic radiopharmaceuticals; apparatus to prepare diagnostic radiopharmaceuticals for delivery; diagnostic imaging apparatus for imaging radiopharmaceuticals, namely, vials, solutions, and infusion devices for preparing and administering diagnostic radiopharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 10, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, June 10, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTelix Pharmaceuticals Limited
Party Type30 - Original Registrant
Legal Entity Type83 - NOT AVAILABLE
AddressAU
Party NameTelix Pharmaceuticals Limited
Party Type20 - Owner at Publication
Legal Entity Type83 - NOT AVAILABLE
AddressAU
Party NameTelix Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type83 - NOT AVAILABLE
AddressAU

Trademark Events

Event DateEvent Description
Thursday, June 6, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, June 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 14, 2019APPLICATION FILING RECEIPT MAILED
Friday, June 14, 2019ASSIGNED TO EXAMINER
Tuesday, June 18, 2019NON-FINAL ACTION WRITTEN
Wednesday, June 19, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 1, 2019REFUSAL PROCESSED BY MPU
Monday, July 1, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 19, 2019REFUSAL PROCESSED BY IB
Monday, November 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 2, 2019FINAL REFUSAL WRITTEN
Monday, December 2, 2019FINAL REFUSAL E-MAILED
Monday, December 2, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 14, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 14, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, January 14, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 14, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, January 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 16, 2020ASSIGNED TO LIE
Wednesday, January 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 29, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 29, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, February 14, 2020NOTIFICATION PROCESSED BY IB
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Tuesday, February 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 18, 2020OPPOSITION NOTICE (IB REFUSAL) CREATED
Tuesday, August 18, 2020OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Wednesday, August 19, 2020OPPOSITION INSTITUTED NO. 999999
Saturday, September 12, 2020REFUSAL PROCESSED BY IB
Wednesday, November 11, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, November 11, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, November 28, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 10, 2021OPPOSITION DISMISSED NO. 999999
Wednesday, February 10, 2021OPPOSITION TERMINATED NO. 999999
Wednesday, February 10, 2021TTAB RELEASE CASE TO TRADEMARKS
Saturday, March 6, 2021LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, March 16, 2021REGISTERED-PRINCIPAL REGISTER
Friday, March 26, 2021LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Wednesday, June 16, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 17, 2021FINAL DISPOSITION PROCESSED
Thursday, June 17, 2021FINAL DISPOSITION NOTICE SENT TO IB
Sunday, July 11, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 23, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, August 5, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sunday, August 14, 2022NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 26, 2026NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

illumet diagnostic radiopharmaceuticals uses radiopharmaceutical infusion imaging preparing administering apparatus devices